6-113859925-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000612661.2(MARCKS):c.345G>T(p.Glu115Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000389 in 1,467,014 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E115K) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000612661.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARCKS | NM_002356.7 | c.345G>T | p.Glu115Asp | missense_variant | 2/2 | ENST00000612661.2 | NP_002347.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARCKS | ENST00000612661.2 | c.345G>T | p.Glu115Asp | missense_variant | 2/2 | 1 | NM_002356.7 | ENSP00000478061.1 |
Frequencies
GnomAD3 genomes AF: 0.0000401 AC: 6AN: 149758Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000125 AC: 11AN: 87976Hom.: 0 AF XY: 0.0000989 AC XY: 5AN XY: 50548
GnomAD4 exome AF: 0.0000372 AC: 49AN: 1317152Hom.: 0 Cov.: 30 AF XY: 0.0000292 AC XY: 19AN XY: 650434
GnomAD4 genome AF: 0.0000534 AC: 8AN: 149862Hom.: 0 Cov.: 32 AF XY: 0.0000684 AC XY: 5AN XY: 73116
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.345G>T (p.E115D) alteration is located in exon 2 (coding exon 2) of the MARCKS gene. This alteration results from a G to T substitution at nucleotide position 345, causing the glutamic acid (E) at amino acid position 115 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at